TransMedics (TMDX) Other Accumulated Expenses (2018 - 2026)
TransMedics has reported Other Accumulated Expenses over the past 8 years, most recently at $18.4 million for Q4 2025.
- For Q4 2025, Other Accumulated Expenses rose 90.42% year-over-year to $18.4 million; the TTM value through Dec 2025 reached $18.4 million, up 90.42%, while the annual FY2025 figure was $18.4 million, 90.42% up from the prior year.
- Other Accumulated Expenses for Q4 2025 was $18.4 million at TransMedics, up from $15.8 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $18.4 million in Q4 2025 and troughed at $1.5 million in Q2 2021.
- A 5-year average of $8.1 million and a median of $5.5 million in 2022 define the central range for Other Accumulated Expenses.
- Biggest five-year swings in Other Accumulated Expenses: tumbled 41.35% in 2023 and later soared 391.46% in 2024.
- Year by year, Other Accumulated Expenses stood at $4.6 million in 2021, then dropped by 5.58% to $4.4 million in 2022, then skyrocketed by 169.56% to $11.8 million in 2023, then dropped by 18.08% to $9.6 million in 2024, then surged by 90.42% to $18.4 million in 2025.
- Business Quant data shows Other Accumulated Expenses for TMDX at $18.4 million in Q4 2025, $15.8 million in Q3 2025, and $12.2 million in Q2 2025.